KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Non-Current Assets: 2011-2025

Historic Non-Current Assets for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $771.1 million.

  • Sarepta Therapeutics' Non-Current Assets fell 15.68% to $771.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $771.1 million, marking a year-over-year decrease of 15.68%. This contributed to the annual value of $889.7 million for FY2024, which is 29.84% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Non-Current Assets stood at $771.1 million for Q3 2025, which was down 24.61% from $1.0 billion recorded in Q2 2025.
  • Over the past 5 years, Sarepta Therapeutics' Non-Current Assets peaked at $1.0 billion during Q1 2025, and registered a low of $476.9 million during Q3 2021.
  • Moreover, its 3-year median value for Non-Current Assets was $759.5 million (2024), whereas its average is $790.9 million.
  • Per our database at Business Quant, Sarepta Therapeutics' Non-Current Assets soared by 38.81% in 2024 and then fell by 15.68% in 2025.
  • Over the past 5 years, Sarepta Therapeutics' Non-Current Assets (Quarterly) stood at $543.9 million in 2021, then increased by 4.90% to $570.5 million in 2022, then grew by 20.11% to $685.2 million in 2023, then climbed by 29.84% to $889.7 million in 2024, then decreased by 15.68% to $771.1 million in 2025.
  • Its Non-Current Assets stands at $771.1 million for Q3 2025, versus $1.0 billion for Q2 2025 and $1.0 billion for Q1 2025.